Retraction
Carvedilol protection against endogenous Aβ-induced neurotoxicity in N2a cells
Paper Information
Record ID:
50387
Journal:
Publication Date:
February 12, 2018
Retraction Date:
December 18, 2023
(1.9 year years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1007/s12192-023-01399-wAdditional Notes:
See also: https://pubpeer.com/publications/A33AEACA091364F5981E9E141E1B21; in January 2024 Elseveir took over as publisher and indexed retraction notice with PMID 38225005.
Citations (24)
24
Total Citations3
Post-Retraction(12.5%)
21
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
411
Days since retraction (latest)
The therapeutic potential of (R)-carvedilol in Huntington's disease through enhancement of autophagy-lysosomal pathway via GSK-3β inhibition
Chih‐Yuan Cheng, Kai-Po Chen, Tien‐Sheng Tseng et al. (5 authors)
Neurotherapeutics
Open Access
Published: Feb 2025
411 days after retraction
Ameliorative Potential of Carvedilol Versus Platelet-Rich Plasma Against Paclitaxel-Induced Femoral Neuropathy in Wistar Rats: A Light and Electron Microscopic Study
Ereny Fekry, George Refaat, Sara Adel Hosny
Microscopy and Microanalysis
Published: Jan 2025
390 days after retraction
Pharmacotherapy of Alzheimer's disease: A thorny road to success
Nurul Husna Ibrahim, Jaya Kumar, Wael Mohamed
Elsevier eBooks
Published: Nov 2024
347 days after retraction
Uncovering the Early Events Associated with Oligomeric Aβ-Induced Src Activation
Sandra I. Mota, Lígia Fão, Patrícia Coelho et al. (4 authors)
Antioxidants
Open Access
Published: Sep 2023
4 citations
4 citations
93 days before retraction
Identification of Azelastine and Carvedilol as Cholinesterase Inhibitors via Structure‐Based Virtual Screening of FDA‐approved Drugs
Mohit Sharma, Shikha Thakur, Hemant R. Jadhav et al. (4 authors)
ChemistrySelect
Published: Jul 2023
5 citations
5 citations
145 days before retraction
Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease using Conjugates of Serotonin with Sesquiterpene Lactones
Маргарита Е. Неганова, Junqi Liu, Yulia Aleksandrova et al. (10 authors)
Current Medicinal Chemistry
Published: Nov 2022
6 citations
6 citations
385 days before retraction
The Role of Caspases in Alzheimer’s Disease: Pathophysiology Implications and Pharmacologic Modulation
Mohammad Rafi Khezri, Morteza Ghasemnejad‐Berenji
Journal of Alzheimer s Disease
Published: Nov 2022
9 citations
9 citations
391 days before retraction
Carvedilol Reduces the Neuronal Apoptosis after Ischemic Stroke by Modulating Activator of Transcription 3 Expression in vitro
Zheng Zhao, Fei Hou, Guodong He et al. (6 authors)
Developmental Neuroscience
Open Access
Published: Oct 2022
8 citations
8 citations
433 days before retraction
Understanding How Physical Exercise Improves Alzheimer’s Disease: Cholinergic and Monoaminergic Systems
Boyi Zong, Fengzhi Yu, Xiaoyou Zhang et al. (7 authors)
Frontiers in Aging Neuroscience
Open Access
Published: May 2022
18 citations
18 citations
579 days before retraction
Carvedilol alleviates lipopolysaccharide (LPS)-induced acute lung injury by inhibiting Ras homolog family member A (RhoA)/ROCK activities
Jing Xu, Zhao Shipin, Li Zhao et al. (4 authors)
Bioengineered
Open Access
Published: Feb 2022
8 citations
8 citations
685 days before retraction
Carvedilol attenuates acrylamide-induced brain damage through inhibition of oxidative, inflammatory, and apoptotic mediators.
Keyvan Amirshahrokhi, Arezoo Abzirakan
PubMed
Published: Jan 2022
13 citations
13 citations
716 days before retraction
Recent Advances in Molecular Pathways and Therapeutic Implications Targeting Mitochondrial Dysfunction for Alzheimer’s Disease
Rishika Dhapola, Phulen Sarma, Bikash Medhi et al. (5 authors)
Molecular Neurobiology
Published: Nov 2021
78 citations
78 citations
776 days before retraction
Carvedilol inhibits Aβ25-35 fibrillation by intervening the early stage helical intermediate formation: A biophysical investigation
Sudeshna Ghosh, Sandeep Verma
International Journal of Biological Macromolecules
Published: Aug 2021
7 citations
7 citations
862 days before retraction
Carvedilol induces the antiapoptotic proteins Nrf2 and Bcl2 and inhibits cellular apoptosis in aluminum-induced testicular toxicity in male Wistar rats
Sanaa A. Ahmed, Walaa Mohammed
Biomedicine & Pharmacotherapy
Open Access
Published: Apr 2021
30 citations
30 citations
974 days before retraction
The Neuroprotective Effect of Carvedilol on Diabetic Neuropathy: An In Vitro Study
Rania Magadmi, Mujahid A. Alsulaimani, Aziza Alrafiah et al. (4 authors)
Journal of Diabetes Research
Open Access
Published: Jan 2021
11 citations
11 citations
1066 days before retraction
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Jiansong Fang, Andrew A. Pieper, Ruth Nussinov et al. (8 authors)
Medicinal Research Reviews
Open Access
Published: Jul 2020
79 citations
79 citations
1253 days before retraction
New Candidate Delivery System for Alzheimer’s Disease: Deferoxamine Nanogels
Hajar Ashrafi, Amir Azadi, Soliman Mohammadi‐Samani et al. (4 authors)
Biointerface Research in Applied Chemistry
Open Access
Published: Jun 2020
20 citations
20 citations
1290 days before retraction
Pharmacotherapy of Alzheimer’s Disease: Seeking Clarity in a Time of Uncertainty
Nurul Husna Ibrahim, Mohamad Fairuz Yahaya, Wael Mohamed et al. (6 authors)
Frontiers in Pharmacology
Open Access
Published: Mar 2020
66 citations
66 citations
1364 days before retraction
Repurposing Antihypertensive Drugs for the Management of Alzheimer’s Disease
Christine Shing Wei Law, Keng Yoon Yeong
Current Medicinal Chemistry
Open Access
Published: Mar 2020
10 citations
10 citations
1376 days before retraction
The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease
Dimitrios Stakos, Κimon Stamatelopoulos, Dimitrios Bampatsias et al. (8 authors)
Journal of the American College of Cardiology
Open Access
Published: Feb 2020
153 citations
153 citations
1393 days before retraction
The role of mitochondrial defects and oxidative stress in Alzheimer’s disease
Badar ul Islam, Nasimudeen R. Jabir, Shams Tabrez
Journal of drug targeting
Published: Feb 2019
40 citations
40 citations
1764 days before retraction
Brusatol inhibits amyloid‐β‐induced neurotoxicity in U‐251 cells via regulating the Nrf2/HO‐1 pathway
Xin Liu, Huawen Xu, YueQi Zhang et al. (5 authors)
Journal of Cellular Biochemistry
Published: Jan 2019
13 citations
13 citations
1803 days before retraction
Alzheimer's Disease and Its Potential Alternative Therapeutics.
Brent R. Kisby, Jarrell Jt, Agar Me et al. (8 authors)
PubMed
Published: Jan 2019
24 citations
24 citations
1812 days before retraction
Recent Advances in the Quest for Treatment and Management of Alzheimer and Other Dementia
Sameena E. Tanwir, Ajay Kumar
Open Journal of Medicinal Chemistry
Open Access
Published: Jan 2019
1 citation
1 citation
1812 days before retraction
Quick Stats
Total Citations:
24
Years Since Retraction:
1.9 year
Open Access:
Yes
Last Checked:
Jul 24, 2025